• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重复电休克刺激诱导大鼠海马体中GluR1信使核糖核酸的产生,但不诱导NMDAR1A-G信使核糖核酸的产生。

Repeated ECS induces GluR1 mRNA but not NMDAR1A-G mRNA in the rat hippocampus.

作者信息

Naylor P, Stewart C A, Wright S R, Pearson R C, Reid I C

机构信息

Department of Psychiatry, University of Sheffield, UK.

出版信息

Brain Res Mol Brain Res. 1996 Jan;35(1-2):349-53. doi: 10.1016/0169-328x(95)00264-s.

DOI:10.1016/0169-328x(95)00264-s
PMID:8717376
Abstract

The neural basis underlying the cognitive side effects of ECT is unknown. Recent studies suggest that the memory dysfunction may be caused by alterations in hippocampal synaptic efficacy [20]. In situ hybridisation was used to examine the possible receptor mechanisms responsible for this effect. Repeated ECS markedly increased mRNA expression for the GluR1 subunit of the AMPA receptor, but not the NMDAR1A-G subtypes of the NMDA receptor, relative to control treatments. This effect was present 24 h after the last seizure and may be responsible for the expression of the ECS-induced increase in synaptic efficacy.

摘要

ECT认知副作用背后的神经基础尚不清楚。最近的研究表明,记忆功能障碍可能是由海马体突触效能的改变引起的[20]。采用原位杂交技术来检测导致这种效应的可能受体机制。相对于对照处理,反复进行电惊厥休克(ECS)显著增加了AMPA受体GluR1亚基的mRNA表达,但未增加NMDA受体的NMDAR1A-G亚型的mRNA表达。这种效应在最后一次癫痫发作后24小时出现,可能是ECS诱导的突触效能增加得以表达的原因。

相似文献

1
Repeated ECS induces GluR1 mRNA but not NMDAR1A-G mRNA in the rat hippocampus.重复电休克刺激诱导大鼠海马体中GluR1信使核糖核酸的产生,但不诱导NMDAR1A-G信使核糖核酸的产生。
Brain Res Mol Brain Res. 1996 Jan;35(1-2):349-53. doi: 10.1016/0169-328x(95)00264-s.
2
In situ hybridization of antisense mRNA oligonucleotides for AMPA, NMDA and metabotropic glutamate receptor subtypes in the rat suprachiasmatic nucleus at different phases of the circadian cycle.在大鼠视交叉上核昼夜节律周期不同阶段,针对AMPA、NMDA和代谢型谷氨酸受体亚型的反义mRNA寡核苷酸的原位杂交。
Brain Res Mol Brain Res. 1994 Jun;23(4):338-44. doi: 10.1016/0169-328x(94)90244-5.
3
Relative concentrations and seizure-induced changes in mRNAs encoding three AMPA receptor subunits in hippocampus and cortex.海马体和皮层中编码三种AMPA受体亚基的mRNA的相对浓度及癫痫发作引起的变化。
J Comp Neurol. 1996 Feb 19;365(4):541-55. doi: 10.1002/(SICI)1096-9861(19960219)365:4<541::AID-CNE3>3.0.CO;2-4.
4
Regional distribution of glutamate receptor mRNA in the monkey hippocampus and temporal cortex: influence of estradiol.
Brain Res Mol Brain Res. 1998 Jan;53(1-2):328-32. doi: 10.1016/s0169-328x(97)00282-9.
5
Age-related changes in expression of AMPA-selective glutamate receptor subunits: is calcium-permeability altered in hippocampal neurons?AMPA 选择性谷氨酸受体亚基表达的年龄相关性变化:海马神经元中的钙通透性是否改变?
Neuroscience. 1994 Aug;61(3):429-33. doi: 10.1016/0306-4522(94)90422-7.
6
Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.大鼠背侧和腹侧海马中NMDA和AMPA受体亚基的差异表达。
Neuroscience. 2006 Jun 19;140(1):163-75. doi: 10.1016/j.neuroscience.2006.02.003. Epub 2006 Mar 20.
7
Differential expression of NMDA and AMPA receptor subunits in DARPP-32-containing neurons of the cerebral cortex, hippocampus and neostriatum of rats.大鼠大脑皮层、海马体和新纹状体中含多巴胺和腺苷酸环化酶激活蛋白-32(DARPP-32)的神经元中N-甲基-D-天冬氨酸(NMDA)和α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体亚基的差异表达
Brain Res. 2004 Feb 20;998(2):174-83. doi: 10.1016/j.brainres.2003.11.034.
8
Alterations of GABA(A) and glutamate receptor subunits and heat shock protein in rat hippocampus following traumatic brain injury and in posttraumatic epilepsy.创伤性脑损伤后及外伤性癫痫大鼠海马中 GABA(A)和谷氨酸受体亚单位及热休克蛋白的改变。
Epilepsy Res. 2011 Jun;95(1-2):20-34. doi: 10.1016/j.eplepsyres.2011.02.008. Epub 2011 Mar 24.
9
Sequential changes in AMPA and NMDA protein levels during Fe(3+)-induced epileptogenesis.铁离子(Fe(3+))诱导癫痫发生过程中AMPA和NMDA蛋白水平的顺序变化。
Brain Res Mol Brain Res. 2001 Aug 15;92(1-2):107-14. doi: 10.1016/s0169-328x(01)00159-0.
10
Distribution of glutamatergic receptors and GAD mRNA-containing neurons in the vestibular nuclei of normal and hemilabyrinthectomized rats.
Eur J Neurosci. 1994 Apr 1;6(4):565-76. doi: 10.1111/j.1460-9568.1994.tb00301.x.

引用本文的文献

1
PKN1 Is a Novel Regulator of Hippocampal GluA1 Levels.PKN1是海马体中谷氨酸受体1(GluA1)水平的新型调节因子。
Front Synaptic Neurosci. 2021 Feb 5;13:640495. doi: 10.3389/fnsyn.2021.640495. eCollection 2021.
2
Increases in iPS Transcription Factor (Oct4, Sox2, c-Myc, and Klf4) Gene Expression after Modified Electroconvulsive Therapy.改良电休克治疗后诱导多能干细胞转录因子(Oct4、Sox2、c-Myc和Klf4)基因表达增加。
Psychiatry Investig. 2015 Oct;12(4):532-7. doi: 10.4306/pi.2015.12.4.532. Epub 2015 Apr 20.
3
An excitatory synapse hypothesis of depression.
抑郁症的兴奋性突触假说。
Trends Neurosci. 2015 May;38(5):279-94. doi: 10.1016/j.tins.2015.03.003. Epub 2015 Apr 14.
4
Microarray Analysis of Human Blood During Electroconvulsive Therapy.电休克治疗期间人体血液的微阵列分析
J ECT. 2015 Dec;31(4):234-7. doi: 10.1097/YCT.0000000000000234.
5
Orchestrated regulation of Nogo receptors, LOTUS, AMPA receptors and BDNF in an ECT model suggests opening and closure of a window of synaptic plasticity.在电休克模型中协调调节 Nogo 受体、LOTUS、AMPA 受体和 BDNF 提示突触可塑性窗口的开启和关闭。
PLoS One. 2013 Nov 14;8(11):e78778. doi: 10.1371/journal.pone.0078778. eCollection 2013.
6
O brother, wherefore are thou? Calcium-permeable AMPA receptors make an appearance in adult status epilepticus.哦,兄弟,你在何处?钙通透性AMPA受体在成人癫痫持续状态中现身了。
Epilepsy Curr. 2013 Jan;13(1):32-4. doi: 10.5698/1535-7511-13.1.32.
7
Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes.抑郁与治疗反应:信号通路和神经过程改变的动态相互作用。
Cell Mol Life Sci. 2013 Jan;70(1):39-53. doi: 10.1007/s00018-012-1020-7. Epub 2012 May 15.
8
Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects.抑郁患者死后海马突触和谷氨酸相关基因表达改变。
Int J Neuropsychopharmacol. 2013 Feb;16(1):69-82. doi: 10.1017/S1461145712000016. Epub 2012 Feb 17.
9
Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.以谷氨酸能信号传导为靶点开发情绪障碍的新型疗法。
Curr Pharm Des. 2009;15(14):1595-611. doi: 10.2174/138161209788168010.
10
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.以谷氨酸能系统为靶点开发用于治疗情绪障碍的新型改良疗法。
Nat Rev Drug Discov. 2008 May;7(5):426-37. doi: 10.1038/nrd2462.